NM_002485.5:c.7A>T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_002485.5(NBN):c.7A>T(p.Lys3*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000274 in 1,460,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002485.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NBN | NM_002485.5 | c.7A>T | p.Lys3* | stop_gained | Exon 1 of 16 | ENST00000265433.8 | NP_002476.2 | |
NBN | XM_011517046.2 | c.7A>T | p.Lys3* | stop_gained | Exon 1 of 11 | XP_011515348.1 | ||
NBN | XM_047421796.1 | c.7A>T | p.Lys3* | stop_gained | Exon 1 of 10 | XP_047277752.1 | ||
NBN | NM_001024688.3 | c.-290A>T | 5_prime_UTR_variant | Exon 1 of 17 | NP_001019859.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245116Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 133866
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460806Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726776
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Microcephaly, normal intelligence and immunodeficiency Pathogenic:2
- -
ClinVar contains an entry for this variant (Variation ID: 492131). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with NBN-related conditions. This variant is present in population databases (rs779098734, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Lys3*) in the NBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBN are known to be pathogenic (PMID: 9590180, 16415040). -
Aplastic anemia;C0023449:Acute lymphoid leukemia;C0398791:Microcephaly, normal intelligence and immunodeficiency Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.K3* variant (also known as c.7A>T), located in coding exon 1 of the NBN gene, results from an A to T substitution at nucleotide position 7. This changes the amino acid from a lysine to a stop codon within coding exon 1. The predicted stop codon occurs in the 5’ end of theNBN gene. Premature termination codons in the 5’ end of a gene have been reported to escape nonsense-mediated mRNAdecay and/or lead to re-initiation (Rivas et al. Science. 2015 May 8;348(6235):666-9; Lindeboom et al. Nat Genet. 2016 Oct;48(10):1112-8; Rhee et al. Sci Rep. 2017 May 10;7(1):1653). Direct evidence for this alteration is unavailable, however premature termination codons are typically deleterious in nature. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at